.png){kind=small}
Therapeutic Phlebotomy for Men on TRT
Testosterone Replacement Therapy (TRT) can be highly effective in improving symptoms of low testosterone, but it may also increase red blood cell production in some men. This can lead to a rise in haematocrit, making regular monitoring and, where appropriate, therapeutic phlebotomy an important part of ongoing treatment.
At The Testosterone Hub, we provide a safe, clinician-led Therapeutic Phlebotomy service for men whose blood results indicate that venesection may be beneficial. Our experienced healthcare professionals carry out the procedure in a comfortable clinical environment using strict infection prevention and safety protocols.
Most appointments take around 20–30 minutes, allowing you to return to your normal routine with minimal disruption.
£110
Who Is This Service For?
Therapeutic Phlebotomy may be appropriate for men who:
-
Are currently receiving Testosterone Replacement Therapy (TRT).
-
Have been advised that their haematocrit or haemoglobin levels are elevated.
-
Have been recommended by their clinician to undergo venesection as part of their TRT management.
-
Require regular blood removal to help maintain appropriate blood parameters whilst continuing testosterone treatment.
A consultation will be completed before treatment to ensure the procedure is appropriate for your individual circumstances.
Preparing for Your Appointment
For the best experience, we recommend:
-
Drinking plenty of water during the 24 hours before your appointment.
-
Eating a light meal within two hours of your visit.
-
Avoiding strenuous exercise immediately beforehand.
-
Wearing clothing with sleeves that can be rolled up easily.
-
Bringing any recent blood test results if requested by our clinical team.
Our Commitment
Your safety is our priority. Every procedure is performed by trained healthcare professionals using sterile, single-use equipment and evidence-based clinical practice.
We work with men throughout their TRT journey, providing a professional, efficient service to help support ongoing treatment when therapeutic phlebotomy has been clinically recommended.